Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)

ClinicalTrials.gov ID: NCT05183919

Public ClinicalTrials.gov record NCT05183919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Arm, Adaptive Design, Pivotal Trial to Assess the Efficacy of AKL-T01, a Novel Digital Intervention Designed to Improve Attention, in Adults Diagnosed With Attention Deficit Hyperactive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effects of the videogame-like digital therapy on attentional functioning and symptoms in Adults diagnosed with ADHD.

Study identification

NCT ID
NCT05183919
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Akili Interactive Labs, Inc.
Industry
Enrollment
223 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2021 (Actual)
Primary completion
Jan 13, 2023 (Actual)
Completion
Jan 13, 2023 (Actual)
Last update posted
Feb 28, 2023

2021 – 2023

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Melmed Center Scottsdale Arizona 85254 —
CNS Clinical Research Trials Garden Grove California 92845 —
Innovative Clinical Research, Inc. Lauderhill Florida 33319 —
Accel Research Sites Maitland Florida 32751 —
Behavioral Clinical Research, Inc. Miami Lakes Florida 33016 —
Midwest Research Group Saint Charles Missouri 63304 —
Alivation Research Lincoln Nebraska 68526 —
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128 —
Hassman Research Institute Berlin New Jersey 08009 —
Albuquerque Neuroscience, Inc. Albuquerque New Mexico 87109 —
MindPath Care Centers Raleigh North Carolina 27606 —
IPS Research Oklahoma City Oklahoma 73106 —
FutureSearch Trials Dallas Texas 75231 —
Southeast Houston Research, Inc. Houston Texas 77089 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05183919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05183919 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →